Epclusa, Filmtabletten

7680660950018 CH-66095 Filmtabletten

Associated product:

EPCLUSA cpr pell bte 28 pce
Epclusa, Filmtabletten
Epclusa, Filmtabletten
Epclusa, Filmtabletten
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/06/2021
Patient information leaflet
Français
09/06/2021
Patient information leaflet
Italien
09/06/2021
Summary of Product Characteristics
Allemand
09/06/2021
Summary of Product Characteristics
Français
09/06/2021
Summary of Product Characteristics
Italien
09/06/2021

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
2.85 MG Substance HBESI

Reimbursement information

Public price
CHF 10389.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2017

Authorization holder

Gilead Sciences Switzerland Sàrl

6300 Zug

Authorization information

Swissmedic authorization number
66095
Drug name
Epclusa, Filmtabletten
Galenic form
FILM
ATC Code
J05AP55
Authorization status
Z
Dispensing category
A
First authorization
22/09/2016
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Chronische Hepatitis C

Package details

Description (FR)
EPCLUSA cpr pell bte 28 pce
Description (DE)
EPCLUSA Filmtabl Ds 28 Stk
Market launch
22/09/2016
Narcotic (BTM)
No